nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—PTGS1—breast cancer	0.263	0.636	CbGaD
Meclofenamic acid—PTGS2—breast cancer	0.15	0.364	CbGaD
Meclofenamic acid—AKR1C3—Doxorubicin—breast cancer	0.12	0.598	CbGbCtD
Meclofenamic acid—SLCO1C1—Methotrexate—breast cancer	0.0668	0.333	CbGbCtD
Meclofenamic acid—SLC22A6—Methotrexate—breast cancer	0.014	0.0696	CbGbCtD
Meclofenamic acid—AKR1C3—nipple—breast cancer	0.00235	0.0545	CbGeAlD
Meclofenamic acid—KCNQ2—pituitary gland—breast cancer	0.00201	0.0466	CbGeAlD
Meclofenamic acid—KCNQ3—female reproductive system—breast cancer	0.002	0.0464	CbGeAlD
Meclofenamic acid—KCNQ2—female reproductive system—breast cancer	0.00184	0.0427	CbGeAlD
Meclofenamic acid—Niclosamide—STAT3—breast cancer	0.00178	0.251	CrCbGaD
Meclofenamic acid—KCNQ2—female gonad—breast cancer	0.00167	0.0388	CbGeAlD
Meclofenamic acid—AKR1C3—Vincristine—Vinorelbine—breast cancer	0.00157	0.384	CbGdCrCtD
Meclofenamic acid—KCNQ2—endocrine gland—breast cancer	0.00156	0.0361	CbGeAlD
Meclofenamic acid—AKR1C3—endometrium—breast cancer	0.00142	0.0329	CbGeAlD
Meclofenamic acid—SLCO1C1—pituitary gland—breast cancer	0.0014	0.0324	CbGeAlD
Meclofenamic acid—SLCO1C1—adipose tissue—breast cancer	0.00139	0.0323	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—NFKBIA—breast cancer	0.00132	0.186	CrCbGaD
Meclofenamic acid—AKR1C3—uterus—breast cancer	0.00131	0.0303	CbGeAlD
Meclofenamic acid—AKR1C3—pituitary gland—breast cancer	0.00129	0.0298	CbGeAlD
Meclofenamic acid—AKR1C3—adipose tissue—breast cancer	0.00128	0.0297	CbGeAlD
Meclofenamic acid—AKR1C3—Vinblastine—Vinorelbine—breast cancer	0.00126	0.309	CbGdCrCtD
Meclofenamic acid—AKR1C3—Vincristine—Vinblastine—breast cancer	0.00125	0.307	CbGdCrCtD
Meclofenamic acid—AKR1C3—adrenal gland—breast cancer	0.00115	0.0266	CbGeAlD
Meclofenamic acid—ALOX5—adipose tissue—breast cancer	0.00113	0.0262	CbGeAlD
Meclofenamic acid—AKR1C3—bone marrow—breast cancer	0.00111	0.0257	CbGeAlD
Meclofenamic acid—SLCO1C1—endocrine gland—breast cancer	0.00108	0.0251	CbGeAlD
Meclofenamic acid—AKR1C3—female gonad—breast cancer	0.00107	0.0248	CbGeAlD
Meclofenamic acid—ALOX5—female reproductive system—breast cancer	0.00104	0.024	CbGeAlD
Meclofenamic acid—ALOX5—adrenal gland—breast cancer	0.00101	0.0235	CbGeAlD
Meclofenamic acid—ALOX5—bone marrow—breast cancer	0.000979	0.0227	CbGeAlD
Meclofenamic acid—ALOX5—female gonad—breast cancer	0.000944	0.0219	CbGeAlD
Meclofenamic acid—ALOX5—endocrine gland—breast cancer	0.000878	0.0203	CbGeAlD
Meclofenamic acid—PTGS1—nipple—breast cancer	0.000832	0.0193	CbGeAlD
Meclofenamic acid—SLCO1C1—lymph node—breast cancer	0.000749	0.0174	CbGeAlD
Meclofenamic acid—AKR1C3—lymph node—breast cancer	0.000688	0.016	CbGeAlD
Meclofenamic acid—PTGS2—embryo—breast cancer	0.000656	0.0152	CbGeAlD
Meclofenamic acid—ALOX5—lymph node—breast cancer	0.000607	0.0141	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—TP53—breast cancer	0.000583	0.0821	CrCbGaD
Meclofenamic acid—PTGS1—epithelium—breast cancer	0.00056	0.013	CbGeAlD
Meclofenamic acid—PTGS2—epithelium—breast cancer	0.000536	0.0124	CbGeAlD
Meclofenamic acid—PTGS1—skin of body—breast cancer	0.000533	0.0124	CbGeAlD
Meclofenamic acid—PTGS2—skin of body—breast cancer	0.000509	0.0118	CbGeAlD
Meclofenamic acid—PTGS1—endometrium—breast cancer	0.000502	0.0116	CbGeAlD
Meclofenamic acid—PTGS2—endometrium—breast cancer	0.00048	0.0111	CbGeAlD
Meclofenamic acid—PTGS1—uterus—breast cancer	0.000463	0.0107	CbGeAlD
Meclofenamic acid—PTGS1—pituitary gland—breast cancer	0.000455	0.0105	CbGeAlD
Meclofenamic acid—PTGS1—adipose tissue—breast cancer	0.000453	0.0105	CbGeAlD
Meclofenamic acid—PTGS2—uterus—breast cancer	0.000443	0.0103	CbGeAlD
Meclofenamic acid—PTGS2—pituitary gland—breast cancer	0.000435	0.0101	CbGeAlD
Meclofenamic acid—PTGS2—adipose tissue—breast cancer	0.000433	0.01	CbGeAlD
Meclofenamic acid—PTGS1—female reproductive system—breast cancer	0.000416	0.00965	CbGeAlD
Meclofenamic acid—PTGS1—adrenal gland—breast cancer	0.000406	0.00942	CbGeAlD
Meclofenamic acid—PTGS2—female reproductive system—breast cancer	0.000398	0.00922	CbGeAlD
Meclofenamic acid—PTGS2—adrenal gland—breast cancer	0.000388	0.009	CbGeAlD
Meclofenamic acid—PTGS1—female gonad—breast cancer	0.000379	0.00878	CbGeAlD
Meclofenamic acid—PTGS2—bone marrow—breast cancer	0.000376	0.00871	CbGeAlD
Meclofenamic acid—PTGS2—female gonad—breast cancer	0.000362	0.00839	CbGeAlD
Meclofenamic acid—PTGS1—endocrine gland—breast cancer	0.000352	0.00817	CbGeAlD
Meclofenamic acid—Lumiracoxib—PTGS1—breast cancer	0.000338	0.0476	CrCbGaD
Meclofenamic acid—PTGS2—endocrine gland—breast cancer	0.000337	0.00781	CbGeAlD
Meclofenamic acid—Diclofenac—ABCC1—breast cancer	0.000326	0.0459	CrCbGaD
Meclofenamic acid—Diclofenac—CXCL8—breast cancer	0.000288	0.0406	CrCbGaD
Meclofenamic acid—Salsalate—PTGS1—breast cancer	0.000267	0.0376	CrCbGaD
Meclofenamic acid—PTGS1—lymph node—breast cancer	0.000244	0.00565	CbGeAlD
Meclofenamic acid—PTGS2—lymph node—breast cancer	0.000233	0.0054	CbGeAlD
Meclofenamic acid—Mefenamic acid—PTGS1—breast cancer	0.000205	0.0288	CrCbGaD
Meclofenamic acid—Acetylsalicylic acid—PTGS1—breast cancer	0.000199	0.0281	CrCbGaD
Meclofenamic acid—Lumiracoxib—PTGS2—breast cancer	0.000193	0.0272	CrCbGaD
Meclofenamic acid—Feeling abnormal—Thiotepa—breast cancer	0.000172	0.000935	CcSEcCtD
Meclofenamic acid—Anorexia—Irinotecan—breast cancer	0.000172	0.000934	CcSEcCtD
Meclofenamic acid—Anorexia—Mitoxantrone—breast cancer	0.000172	0.000934	CcSEcCtD
Meclofenamic acid—Diarrhoea—Melphalan—breast cancer	0.000171	0.000931	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Thiotepa—breast cancer	0.000171	0.000928	CcSEcCtD
Meclofenamic acid—Haemoglobin—Capecitabine—breast cancer	0.000171	0.000928	CcSEcCtD
Meclofenamic acid—Nausea—Chlorambucil—breast cancer	0.000171	0.000927	CcSEcCtD
Meclofenamic acid—Haemorrhage—Capecitabine—breast cancer	0.00017	0.000923	CcSEcCtD
Meclofenamic acid—Vision blurred—Paclitaxel—breast cancer	0.00017	0.000923	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—breast cancer	0.000168	0.000912	CcSEcCtD
Meclofenamic acid—Anorexia—Gemcitabine—breast cancer	0.000168	0.00091	CcSEcCtD
Meclofenamic acid—Vomiting—Vinblastine—breast cancer	0.000168	0.000909	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Paclitaxel—breast cancer	0.000167	0.000909	CcSEcCtD
Meclofenamic acid—Diarrhoea—Goserelin—breast cancer	0.000167	0.000908	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Docetaxel—breast cancer	0.000166	0.000902	CcSEcCtD
Meclofenamic acid—Urticaria—Thiotepa—breast cancer	0.000166	0.000901	CcSEcCtD
Meclofenamic acid—Abdominal pain—Thiotepa—breast cancer	0.000165	0.000897	CcSEcCtD
Meclofenamic acid—Anorexia—Fluorouracil—breast cancer	0.000165	0.000895	CcSEcCtD
Meclofenamic acid—Salicylic acid—PTGS1—breast cancer	0.000164	0.0231	CrCbGaD
Meclofenamic acid—Insomnia—Irinotecan—breast cancer	0.000163	0.000886	CcSEcCtD
Meclofenamic acid—Vomiting—Tamoxifen—breast cancer	0.000163	0.000883	CcSEcCtD
Meclofenamic acid—Malaise—Paclitaxel—breast cancer	0.000163	0.000883	CcSEcCtD
Meclofenamic acid—Paraesthesia—Irinotecan—breast cancer	0.000162	0.00088	CcSEcCtD
Meclofenamic acid—Paraesthesia—Mitoxantrone—breast cancer	0.000162	0.00088	CcSEcCtD
Meclofenamic acid—Leukopenia—Paclitaxel—breast cancer	0.000162	0.000877	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Capecitabine—breast cancer	0.000161	0.000873	CcSEcCtD
Meclofenamic acid—Palpitations—Paclitaxel—breast cancer	0.000159	0.000865	CcSEcCtD
Meclofenamic acid—Vomiting—Melphalan—breast cancer	0.000159	0.000865	CcSEcCtD
Meclofenamic acid—Insomnia—Gemcitabine—breast cancer	0.000159	0.000863	CcSEcCtD
Meclofenamic acid—Tinnitus—Capecitabine—breast cancer	0.000159	0.000861	CcSEcCtD
Meclofenamic acid—Paraesthesia—Gemcitabine—breast cancer	0.000158	0.000857	CcSEcCtD
Meclofenamic acid—Asthenia—Vinorelbine—breast cancer	0.000157	0.000853	CcSEcCtD
Meclofenamic acid—Decreased appetite—Irinotecan—breast cancer	0.000157	0.000852	CcSEcCtD
Meclofenamic acid—Decreased appetite—Mitoxantrone—breast cancer	0.000157	0.000852	CcSEcCtD
Meclofenamic acid—Eosinophilia—Methotrexate—breast cancer	0.000157	0.00085	CcSEcCtD
Meclofenamic acid—Nausea—Vinblastine—breast cancer	0.000156	0.000849	CcSEcCtD
Meclofenamic acid—Insomnia—Fluorouracil—breast cancer	0.000156	0.000849	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Irinotecan—breast cancer	0.000156	0.000846	CcSEcCtD
Meclofenamic acid—Fatigue—Mitoxantrone—breast cancer	0.000156	0.000845	CcSEcCtD
Meclofenamic acid—Fatigue—Irinotecan—breast cancer	0.000156	0.000845	CcSEcCtD
Meclofenamic acid—Vomiting—Goserelin—breast cancer	0.000155	0.000844	CcSEcCtD
Meclofenamic acid—Paraesthesia—Fluorouracil—breast cancer	0.000155	0.000843	CcSEcCtD
Meclofenamic acid—Alopecia—Docetaxel—breast cancer	0.000155	0.000843	CcSEcCtD
Meclofenamic acid—Pruritus—Vinorelbine—breast cancer	0.000155	0.000841	CcSEcCtD
Meclofenamic acid—Constipation—Irinotecan—breast cancer	0.000154	0.000838	CcSEcCtD
Meclofenamic acid—Constipation—Mitoxantrone—breast cancer	0.000154	0.000838	CcSEcCtD
Meclofenamic acid—Decreased appetite—Gemcitabine—breast cancer	0.000153	0.00083	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—breast cancer	0.000153	0.0215	CrCbGaD
Meclofenamic acid—Nausea—Tamoxifen—breast cancer	0.000152	0.000825	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000152	0.000824	CcSEcCtD
Meclofenamic acid—Discomfort—Paclitaxel—breast cancer	0.000152	0.000824	CcSEcCtD
Meclofenamic acid—Fatigue—Gemcitabine—breast cancer	0.000152	0.000823	CcSEcCtD
Meclofenamic acid—Constipation—Gemcitabine—breast cancer	0.00015	0.000816	CcSEcCtD
Meclofenamic acid—Decreased appetite—Fluorouracil—breast cancer	0.00015	0.000816	CcSEcCtD
Meclofenamic acid—Alopecia—Capecitabine—breast cancer	0.00015	0.000816	CcSEcCtD
Meclofenamic acid—Asthenia—Thiotepa—breast cancer	0.00015	0.000814	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vinorelbine—breast cancer	0.00015	0.000813	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000149	0.00081	CcSEcCtD
Meclofenamic acid—Nausea—Melphalan—breast cancer	0.000149	0.000808	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Mitoxantrone—breast cancer	0.000149	0.000808	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Irinotecan—breast cancer	0.000149	0.000808	CcSEcCtD
Meclofenamic acid—Neutropenia—Methotrexate—breast cancer	0.000148	0.000803	CcSEcCtD
Meclofenamic acid—Pruritus—Thiotepa—breast cancer	0.000148	0.000803	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000148	0.000801	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Irinotecan—breast cancer	0.000148	0.000801	CcSEcCtD
Meclofenamic acid—Oedema—Paclitaxel—breast cancer	0.000147	0.000799	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS1—breast cancer	0.000147	0.0207	CrCbGaD
Meclofenamic acid—Eosinophilia—Epirubicin—breast cancer	0.000147	0.000796	CcSEcCtD
Meclofenamic acid—Nausea—Goserelin—breast cancer	0.000145	0.000788	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Gemcitabine—breast cancer	0.000145	0.000787	CcSEcCtD
Meclofenamic acid—Urticaria—Mitoxantrone—breast cancer	0.000143	0.000779	CcSEcCtD
Meclofenamic acid—Diarrhoea—Thiotepa—breast cancer	0.000143	0.000776	CcSEcCtD
Meclofenamic acid—Abdominal pain—Irinotecan—breast cancer	0.000143	0.000775	CcSEcCtD
Meclofenamic acid—Abdominal pain—Mitoxantrone—breast cancer	0.000143	0.000775	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Fluorouracil—breast cancer	0.000143	0.000773	CcSEcCtD
Meclofenamic acid—Anorexia—Paclitaxel—breast cancer	0.00014	0.000762	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.00014	0.000759	CcSEcCtD
Meclofenamic acid—Vision blurred—Capecitabine—breast cancer	0.00014	0.000757	CcSEcCtD
Meclofenamic acid—Vomiting—Vinorelbine—breast cancer	0.000139	0.000755	CcSEcCtD
Meclofenamic acid—Renal failure—Methotrexate—breast cancer	0.000139	0.000753	CcSEcCtD
Meclofenamic acid—Neutropenia—Epirubicin—breast cancer	0.000138	0.000751	CcSEcCtD
Meclofenamic acid—Stomatitis—Methotrexate—breast cancer	0.000137	0.000746	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Capecitabine—breast cancer	0.000137	0.000746	CcSEcCtD
Meclofenamic acid—Urticaria—Fluorouracil—breast cancer	0.000137	0.000746	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Methotrexate—breast cancer	0.000137	0.000744	CcSEcCtD
Meclofenamic acid—Leukopenia—Docetaxel—breast cancer	0.000137	0.000743	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—breast cancer	0.000136	0.000736	CcSEcCtD
Meclofenamic acid—Palpitations—Docetaxel—breast cancer	0.000135	0.000734	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP1A1—breast cancer	0.000134	0.0189	CrCbGaD
Meclofenamic acid—Malaise—Capecitabine—breast cancer	0.000134	0.000725	CcSEcCtD
Meclofenamic acid—Insomnia—Paclitaxel—breast cancer	0.000133	0.000723	CcSEcCtD
Meclofenamic acid—Vomiting—Thiotepa—breast cancer	0.000133	0.000722	CcSEcCtD
Meclofenamic acid—Leukopenia—Capecitabine—breast cancer	0.000133	0.000719	CcSEcCtD
Meclofenamic acid—Paraesthesia—Paclitaxel—breast cancer	0.000132	0.000718	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Methotrexate—breast cancer	0.000132	0.000714	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000131	0.00071	CcSEcCtD
Meclofenamic acid—Palpitations—Capecitabine—breast cancer	0.000131	0.00071	CcSEcCtD
Meclofenamic acid—Nausea—Vinorelbine—breast cancer	0.00013	0.000706	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—breast cancer	0.00013	0.000704	CcSEcCtD
Meclofenamic acid—Asthenia—Mitoxantrone—breast cancer	0.00013	0.000703	CcSEcCtD
Meclofenamic acid—Asthenia—Irinotecan—breast cancer	0.00013	0.000703	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—breast cancer	0.000129	0.000698	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—breast cancer	0.000128	0.000696	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—breast cancer	0.000128	0.000695	CcSEcCtD
Meclofenamic acid—Decreased appetite—Paclitaxel—breast cancer	0.000128	0.000695	CcSEcCtD
Meclofenamic acid—Haemoglobin—Methotrexate—breast cancer	0.000127	0.000691	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000127	0.00069	CcSEcCtD
Meclofenamic acid—Fatigue—Paclitaxel—breast cancer	0.000127	0.000689	CcSEcCtD
Meclofenamic acid—Haemorrhage—Methotrexate—breast cancer	0.000127	0.000687	CcSEcCtD
Meclofenamic acid—Asthenia—Gemcitabine—breast cancer	0.000126	0.000685	CcSEcCtD
Meclofenamic acid—Constipation—Paclitaxel—breast cancer	0.000126	0.000683	CcSEcCtD
Meclofenamic acid—Oedema—Docetaxel—breast cancer	0.000125	0.000677	CcSEcCtD
Meclofenamic acid—Discomfort—Capecitabine—breast cancer	0.000125	0.000676	CcSEcCtD
Meclofenamic acid—Pruritus—Gemcitabine—breast cancer	0.000124	0.000675	CcSEcCtD
Meclofenamic acid—Nausea—Thiotepa—breast cancer	0.000124	0.000674	CcSEcCtD
Meclofenamic acid—Diarrhoea—Mitoxantrone—breast cancer	0.000124	0.00067	CcSEcCtD
Meclofenamic acid—Diarrhoea—Irinotecan—breast cancer	0.000124	0.00067	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Epirubicin—breast cancer	0.000123	0.000669	CcSEcCtD
Meclofenamic acid—Pruritus—Fluorouracil—breast cancer	0.000122	0.000664	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Paclitaxel—breast cancer	0.000121	0.000659	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000121	0.000657	CcSEcCtD
Meclofenamic acid—Oedema—Capecitabine—breast cancer	0.000121	0.000656	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Paclitaxel—breast cancer	0.00012	0.000654	CcSEcCtD
Meclofenamic acid—Diarrhoea—Gemcitabine—breast cancer	0.00012	0.000653	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—breast cancer	0.00012	0.000652	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Methotrexate—breast cancer	0.00012	0.00065	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—breast cancer	0.000119	0.000646	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—breast cancer	0.000119	0.000646	CcSEcCtD
Meclofenamic acid—Anorexia—Docetaxel—breast cancer	0.000119	0.000646	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—breast cancer	0.000119	0.000644	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—breast cancer	0.000119	0.000643	CcSEcCtD
Meclofenamic acid—Diarrhoea—Fluorouracil—breast cancer	0.000118	0.000642	CcSEcCtD
Meclofenamic acid—Tinnitus—Methotrexate—breast cancer	0.000118	0.000641	CcSEcCtD
Meclofenamic acid—Urticaria—Paclitaxel—breast cancer	0.000117	0.000635	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS2—breast cancer	0.000117	0.0165	CrCbGaD
Meclofenamic acid—Abdominal pain—Paclitaxel—breast cancer	0.000116	0.000632	CcSEcCtD
Meclofenamic acid—Anorexia—Capecitabine—breast cancer	0.000115	0.000625	CcSEcCtD
Meclofenamic acid—Vomiting—Irinotecan—breast cancer	0.000115	0.000623	CcSEcCtD
Meclofenamic acid—Vomiting—Mitoxantrone—breast cancer	0.000115	0.000623	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Doxorubicin—breast cancer	0.000114	0.000619	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—breast cancer	0.000114	0.0161	CrCbGaD
Meclofenamic acid—Insomnia—Docetaxel—breast cancer	0.000113	0.000613	CcSEcCtD
Meclofenamic acid—Paraesthesia—Docetaxel—breast cancer	0.000112	0.000608	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Epirubicin—breast cancer	0.000112	0.000608	CcSEcCtD
Meclofenamic acid—Alopecia—Methotrexate—breast cancer	0.000112	0.000607	CcSEcCtD
Meclofenamic acid—Vomiting—Gemcitabine—breast cancer	0.000112	0.000607	CcSEcCtD
Meclofenamic acid—Tinnitus—Epirubicin—breast cancer	0.00011	0.0006	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—breast cancer	0.00011	0.000598	CcSEcCtD
Meclofenamic acid—Vomiting—Fluorouracil—breast cancer	0.00011	0.000597	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—breast cancer	0.00011	0.000595	CcSEcCtD
Meclofenamic acid—Insomnia—Capecitabine—breast cancer	0.000109	0.000593	CcSEcCtD
Meclofenamic acid—Paraesthesia—Capecitabine—breast cancer	0.000109	0.000589	CcSEcCtD
Meclofenamic acid—Decreased appetite—Docetaxel—breast cancer	0.000109	0.000589	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Docetaxel—breast cancer	0.000108	0.000585	CcSEcCtD
Meclofenamic acid—Fatigue—Docetaxel—breast cancer	0.000108	0.000584	CcSEcCtD
Meclofenamic acid—Nausea—Irinotecan—breast cancer	0.000107	0.000582	CcSEcCtD
Meclofenamic acid—Nausea—Mitoxantrone—breast cancer	0.000107	0.000582	CcSEcCtD
Meclofenamic acid—Constipation—Docetaxel—breast cancer	0.000107	0.000579	CcSEcCtD
Meclofenamic acid—Asthenia—Paclitaxel—breast cancer	0.000106	0.000573	CcSEcCtD
Meclofenamic acid—Decreased appetite—Capecitabine—breast cancer	0.000105	0.00057	CcSEcCtD
Meclofenamic acid—Alopecia—Epirubicin—breast cancer	0.000105	0.000568	CcSEcCtD
Meclofenamic acid—Nausea—Gemcitabine—breast cancer	0.000104	0.000567	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Capecitabine—breast cancer	0.000104	0.000566	CcSEcCtD
Meclofenamic acid—Fatigue—Capecitabine—breast cancer	0.000104	0.000565	CcSEcCtD
Meclofenamic acid—Pruritus—Paclitaxel—breast cancer	0.000104	0.000565	CcSEcCtD
Meclofenamic acid—Vision blurred—Methotrexate—breast cancer	0.000104	0.000564	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—breast cancer	0.000104	0.000563	CcSEcCtD
Meclofenamic acid—Constipation—Capecitabine—breast cancer	0.000103	0.000561	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Docetaxel—breast cancer	0.000103	0.000558	CcSEcCtD
Meclofenamic acid—Nausea—Fluorouracil—breast cancer	0.000103	0.000557	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Methotrexate—breast cancer	0.000102	0.000555	CcSEcCtD
Meclofenamic acid—Tinnitus—Doxorubicin—breast cancer	0.000102	0.000555	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Docetaxel—breast cancer	0.000102	0.000554	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—ALB—breast cancer	0.000102	0.0143	CrCbGaD
Meclofenamic acid—Diarrhoea—Paclitaxel—breast cancer	0.000101	0.000547	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Capecitabine—breast cancer	9.96e-05	0.00054	CcSEcCtD
Meclofenamic acid—Malaise—Methotrexate—breast cancer	9.94e-05	0.000539	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Capecitabine—breast cancer	9.88e-05	0.000536	CcSEcCtD
Meclofenamic acid—Abdominal pain—Docetaxel—breast cancer	9.87e-05	0.000536	CcSEcCtD
Meclofenamic acid—Leukopenia—Methotrexate—breast cancer	9.87e-05	0.000536	CcSEcCtD
Meclofenamic acid—Vision blurred—Epirubicin—breast cancer	9.72e-05	0.000528	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—breast cancer	9.69e-05	0.000526	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—ABCB1—breast cancer	9.69e-05	0.0137	CrCbGaD
Meclofenamic acid—Urticaria—Capecitabine—breast cancer	9.6e-05	0.000521	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—breast cancer	9.57e-05	0.000519	CcSEcCtD
Meclofenamic acid—Abdominal pain—Capecitabine—breast cancer	9.55e-05	0.000518	CcSEcCtD
Meclofenamic acid—Salicylic acid—PTGS2—breast cancer	9.38e-05	0.0132	CrCbGaD
Meclofenamic acid—Vomiting—Paclitaxel—breast cancer	9.36e-05	0.000508	CcSEcCtD
Meclofenamic acid—Malaise—Epirubicin—breast cancer	9.3e-05	0.000505	CcSEcCtD
Meclofenamic acid—Discomfort—Methotrexate—breast cancer	9.27e-05	0.000503	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—breast cancer	9.23e-05	0.000501	CcSEcCtD
Meclofenamic acid—Palpitations—Epirubicin—breast cancer	9.12e-05	0.000495	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—breast cancer	9e-05	0.000488	CcSEcCtD
Meclofenamic acid—Asthenia—Docetaxel—breast cancer	8.96e-05	0.000486	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—breast cancer	8.86e-05	0.000481	CcSEcCtD
Meclofenamic acid—Pruritus—Docetaxel—breast cancer	8.83e-05	0.000479	CcSEcCtD
Meclofenamic acid—Nausea—Paclitaxel—breast cancer	8.75e-05	0.000475	CcSEcCtD
Meclofenamic acid—Discomfort—Epirubicin—breast cancer	8.68e-05	0.000471	CcSEcCtD
Meclofenamic acid—Asthenia—Capecitabine—breast cancer	8.67e-05	0.000471	CcSEcCtD
Meclofenamic acid—Malaise—Doxorubicin—breast cancer	8.61e-05	0.000467	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP3A4—breast cancer	8.58e-05	0.0121	CrCbGaD
Meclofenamic acid—Anorexia—Methotrexate—breast cancer	8.58e-05	0.000465	CcSEcCtD
Meclofenamic acid—Pruritus—Capecitabine—breast cancer	8.55e-05	0.000464	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—breast cancer	8.54e-05	0.000464	CcSEcCtD
Meclofenamic acid—Diarrhoea—Docetaxel—breast cancer	8.54e-05	0.000463	CcSEcCtD
Meclofenamic acid—Palpitations—Doxorubicin—breast cancer	8.44e-05	0.000458	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—breast cancer	8.42e-05	0.000457	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS2—breast cancer	8.4e-05	0.0118	CrCbGaD
Meclofenamic acid—Salicylic acid—ALB—breast cancer	8.36e-05	0.0118	CrCbGaD
Meclofenamic acid—Diarrhoea—Capecitabine—breast cancer	8.27e-05	0.000449	CcSEcCtD
Meclofenamic acid—Insomnia—Methotrexate—breast cancer	8.14e-05	0.000442	CcSEcCtD
Meclofenamic acid—Paraesthesia—Methotrexate—breast cancer	8.08e-05	0.000438	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—breast cancer	8.03e-05	0.000436	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—breast cancer	8.03e-05	0.000436	CcSEcCtD
Meclofenamic acid—Salicylic acid—ABCB1—breast cancer	7.98e-05	0.0112	CrCbGaD
Meclofenamic acid—Vomiting—Docetaxel—breast cancer	7.94e-05	0.000431	CcSEcCtD
Meclofenamic acid—Decreased appetite—Methotrexate—breast cancer	7.82e-05	0.000424	CcSEcCtD
Meclofenamic acid—Oedema—Doxorubicin—breast cancer	7.79e-05	0.000423	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Methotrexate—breast cancer	7.77e-05	0.000422	CcSEcCtD
Meclofenamic acid—Fatigue—Methotrexate—breast cancer	7.76e-05	0.000421	CcSEcCtD
Meclofenamic acid—Vomiting—Capecitabine—breast cancer	7.68e-05	0.000417	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—breast cancer	7.61e-05	0.000413	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—breast cancer	7.56e-05	0.00041	CcSEcCtD
Meclofenamic acid—Diclofenac—ALB—breast cancer	7.48e-05	0.0106	CrCbGaD
Meclofenamic acid—Anorexia—Doxorubicin—breast cancer	7.43e-05	0.000403	CcSEcCtD
Meclofenamic acid—Nausea—Docetaxel—breast cancer	7.41e-05	0.000402	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Methotrexate—breast cancer	7.41e-05	0.000402	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Methotrexate—breast cancer	7.36e-05	0.000399	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—breast cancer	7.32e-05	0.000397	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—breast cancer	7.27e-05	0.000394	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—breast cancer	7.26e-05	0.000394	CcSEcCtD
Meclofenamic acid—Constipation—Epirubicin—breast cancer	7.2e-05	0.000391	CcSEcCtD
Meclofenamic acid—Nausea—Capecitabine—breast cancer	7.18e-05	0.00039	CcSEcCtD
Meclofenamic acid—Urticaria—Methotrexate—breast cancer	7.15e-05	0.000388	CcSEcCtD
Meclofenamic acid—Diclofenac—ABCB1—breast cancer	7.14e-05	0.0101	CrCbGaD
Meclofenamic acid—Abdominal pain—Methotrexate—breast cancer	7.11e-05	0.000386	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—breast cancer	7.05e-05	0.000382	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—breast cancer	7e-05	0.00038	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Epirubicin—breast cancer	6.94e-05	0.000377	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—breast cancer	6.88e-05	0.000374	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—breast cancer	6.77e-05	0.000368	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—breast cancer	6.73e-05	0.000365	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—breast cancer	6.72e-05	0.000364	CcSEcCtD
Meclofenamic acid—Urticaria—Epirubicin—breast cancer	6.69e-05	0.000363	CcSEcCtD
Meclofenamic acid—Constipation—Doxorubicin—breast cancer	6.66e-05	0.000362	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—breast cancer	6.66e-05	0.000361	CcSEcCtD
Meclofenamic acid—Asthenia—Methotrexate—breast cancer	6.45e-05	0.00035	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Doxorubicin—breast cancer	6.42e-05	0.000348	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—breast cancer	6.37e-05	0.000346	CcSEcCtD
Meclofenamic acid—Pruritus—Methotrexate—breast cancer	6.37e-05	0.000345	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—breast cancer	6.19e-05	0.000336	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—breast cancer	6.16e-05	0.000334	CcSEcCtD
Meclofenamic acid—Diarrhoea—Methotrexate—breast cancer	6.16e-05	0.000334	CcSEcCtD
Meclofenamic acid—Asthenia—Epirubicin—breast cancer	6.04e-05	0.000328	CcSEcCtD
Meclofenamic acid—Pruritus—Epirubicin—breast cancer	5.96e-05	0.000323	CcSEcCtD
Meclofenamic acid—Diarrhoea—Epirubicin—breast cancer	5.76e-05	0.000313	CcSEcCtD
Meclofenamic acid—Vomiting—Methotrexate—breast cancer	5.72e-05	0.00031	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—breast cancer	5.59e-05	0.000303	CcSEcCtD
Meclofenamic acid—Pruritus—Doxorubicin—breast cancer	5.51e-05	0.000299	CcSEcCtD
Meclofenamic acid—Vomiting—Epirubicin—breast cancer	5.35e-05	0.000291	CcSEcCtD
Meclofenamic acid—Nausea—Methotrexate—breast cancer	5.34e-05	0.00029	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—breast cancer	5.33e-05	0.000289	CcSEcCtD
Meclofenamic acid—Nausea—Epirubicin—breast cancer	5e-05	0.000271	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—breast cancer	4.95e-05	0.000269	CcSEcCtD
Meclofenamic acid—Nausea—Doxorubicin—breast cancer	4.63e-05	0.000251	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—PIK3CB—breast cancer	1.16e-05	7.86e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CD4—breast cancer	1.15e-05	7.85e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KDR—breast cancer	1.15e-05	7.8e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—breast cancer	1.14e-05	7.79e-05	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	1.14e-05	7.75e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ESR1—breast cancer	1.12e-05	7.6e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CD—breast cancer	1.11e-05	7.59e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CD—breast cancer	1.11e-05	7.56e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FN1—breast cancer	1.1e-05	7.51e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ALB—breast cancer	1.1e-05	7.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP17A1—breast cancer	1.1e-05	7.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.1e-05	7.46e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ALB—breast cancer	1.1e-05	7.46e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NFKBIA—breast cancer	1.09e-05	7.42e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ENO1—breast cancer	1.09e-05	7.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.08e-05	7.39e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1B—breast cancer	1.08e-05	7.38e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NOTCH1—breast cancer	1.08e-05	7.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HSPA1B—breast cancer	1.08e-05	7.33e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.08e-05	7.32e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.07e-05	7.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP2D6—breast cancer	1.07e-05	7.27e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.06e-05	7.22e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APC—breast cancer	1.06e-05	7.19e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CG—breast cancer	1.06e-05	7.19e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KIT—breast cancer	1.06e-05	7.19e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—NOS3—breast cancer	1.05e-05	7.16e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NOS3—breast cancer	1.05e-05	7.14e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NCOA2—breast cancer	1.05e-05	7.14e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGF—breast cancer	1.04e-05	7.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MED12—breast cancer	1.04e-05	7.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—DPYD—breast cancer	1.04e-05	7.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ENO1—breast cancer	1.03e-05	7.03e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALDOA—breast cancer	1.03e-05	6.99e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CTNNB1—breast cancer	1.02e-05	6.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—FASN—breast cancer	1.02e-05	6.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—BCHE—breast cancer	1.01e-05	6.89e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1A—breast cancer	1e-05	6.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC5A5—breast cancer	1e-05	6.81e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—breast cancer	9.98e-06	6.8e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA3—breast cancer	9.97e-06	6.79e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BRAF—breast cancer	9.92e-06	6.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC2A2—breast cancer	9.9e-06	6.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.8e-06	6.67e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF3—breast cancer	9.76e-06	6.64e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CB—breast cancer	9.71e-06	6.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CPT1A—breast cancer	9.7e-06	6.6e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ABCG2—breast cancer	9.7e-06	6.6e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTR—breast cancer	9.7e-06	6.6e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CB—breast cancer	9.67e-06	6.59e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF1—breast cancer	9.67e-06	6.58e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT2—breast cancer	9.66e-06	6.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NQO1—breast cancer	9.66e-06	6.57e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC2A1—breast cancer	9.66e-06	6.57e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—JAG1—breast cancer	9.64e-06	6.56e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FASN—breast cancer	9.64e-06	6.56e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—breast cancer	9.62e-06	6.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PARP1—breast cancer	9.6e-06	6.53e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—breast cancer	9.59e-06	6.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HPGDS—breast cancer	9.51e-06	6.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CALCA—breast cancer	9.48e-06	6.45e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.46e-06	6.44e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HBA1—breast cancer	9.45e-06	6.43e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP3A4—breast cancer	9.42e-06	6.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.37e-06	6.38e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RPS6—breast cancer	9.37e-06	6.38e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF4—breast cancer	9.29e-06	6.33e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CD—breast cancer	9.28e-06	6.32e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1B1—breast cancer	9.26e-06	6.3e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CXCR4—breast cancer	9.26e-06	6.3e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SRC—breast cancer	9.26e-06	6.3e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTT1—breast cancer	9.22e-06	6.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ACHE—breast cancer	9.22e-06	6.28e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SERPINE1—breast cancer	9.18e-06	6.25e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC2A1—breast cancer	9.15e-06	6.23e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HSP90AA1—breast cancer	9.08e-06	6.18e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	8.95e-06	6.09e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—STAT3—breast cancer	8.93e-06	6.08e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TCF7L2—breast cancer	8.93e-06	6.08e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NCOA1—breast cancer	8.83e-06	6.01e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NOS3—breast cancer	8.76e-06	5.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP17A1—breast cancer	8.73e-06	5.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—STK11—breast cancer	8.7e-06	5.93e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP19A1—breast cancer	8.7e-06	5.93e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ENO1—breast cancer	8.64e-06	5.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTGS1—breast cancer	8.64e-06	5.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.61e-06	5.86e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HSP90AA1—breast cancer	8.61e-06	5.86e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MAPK3—breast cancer	8.53e-06	5.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.5e-06	5.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP2D6—breast cancer	8.48e-06	5.77e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—breast cancer	8.39e-06	5.71e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRL—breast cancer	8.37e-06	5.7e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—breast cancer	8.36e-06	5.69e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA2—breast cancer	8.32e-06	5.66e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MDM2—breast cancer	8.31e-06	5.66e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MYC—breast cancer	8.3e-06	5.65e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RAF1—breast cancer	8.29e-06	5.64e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TGFB1—breast cancer	8.28e-06	5.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ADAM10—breast cancer	8.25e-06	5.62e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RELA—breast cancer	8.25e-06	5.62e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ERBB2—breast cancer	8.2e-06	5.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.17e-06	5.56e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EGFR—breast cancer	8.11e-06	5.52e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—COMT—breast cancer	8.09e-06	5.51e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CB—breast cancer	8.09e-06	5.51e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MTOR—breast cancer	8.09e-06	5.51e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—FASN—breast cancer	8.07e-06	5.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTP1—breast cancer	8.05e-06	5.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—BCHE—breast cancer	8.04e-06	5.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF10—breast cancer	8.03e-06	5.46e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HMOX1—breast cancer	7.94e-06	5.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A5—breast cancer	7.94e-06	5.4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ITPR1—breast cancer	7.93e-06	5.4e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCL8—breast cancer	7.77e-06	5.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PDGFA—breast cancer	7.75e-06	5.27e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NQO1—breast cancer	7.67e-06	5.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC2A1—breast cancer	7.67e-06	5.22e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—breast cancer	7.67e-06	5.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFBR2—breast cancer	7.63e-06	5.2e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ABCB1—breast cancer	7.62e-06	5.19e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1B—breast cancer	7.59e-06	5.17e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ITPR1—breast cancer	7.51e-06	5.11e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.51e-06	5.11e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TYMS—breast cancer	7.49e-06	5.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP3A4—breast cancer	7.48e-06	5.09e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB4—breast cancer	7.46e-06	5.08e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT5A—breast cancer	7.46e-06	5.08e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CASP3—breast cancer	7.44e-06	5.07e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2—breast cancer	7.43e-06	5.06e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PLA2G4A—breast cancer	7.4e-06	5.04e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NCOR1—breast cancer	7.4e-06	5.04e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTM1—breast cancer	7.4e-06	5.04e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1B1—breast cancer	7.35e-06	5e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—breast cancer	7.24e-06	4.93e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JUN—breast cancer	7.23e-06	4.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SMAD4—breast cancer	7.23e-06	4.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HSP90AA1—breast cancer	7.21e-06	4.91e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CTNNB1—breast cancer	7.17e-06	4.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GPX1—breast cancer	7.09e-06	4.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HES1—breast cancer	7.06e-06	4.8e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CA—breast cancer	7.04e-06	4.79e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MMP9—breast cancer	7.03e-06	4.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1A1—breast cancer	7.02e-06	4.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NCOR1—breast cancer	7.02e-06	4.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA1—breast cancer	7.01e-06	4.77e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1A—breast cancer	7.01e-06	4.77e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—breast cancer	6.99e-06	4.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ERCC2—breast cancer	6.96e-06	4.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF1—breast cancer	6.94e-06	4.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—STK11—breast cancer	6.91e-06	4.7e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP19A1—breast cancer	6.91e-06	4.7e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRG1—breast cancer	6.89e-06	4.69e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK8—breast cancer	6.84e-06	4.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—H2AFX—breast cancer	6.84e-06	4.65e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERCC2—breast cancer	6.6e-06	4.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTHFR—breast cancer	6.54e-06	4.45e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—breast cancer	6.52e-06	4.44e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.49e-06	4.42e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SRC—breast cancer	6.48e-06	4.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB3—breast cancer	6.45e-06	4.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGFR2—breast cancer	6.44e-06	4.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—COMT—breast cancer	6.42e-06	4.37e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTP1—breast cancer	6.39e-06	4.35e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—breast cancer	6.31e-06	4.3e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HMOX1—breast cancer	6.31e-06	4.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ITPR1—breast cancer	6.29e-06	4.28e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—STAT3—breast cancer	6.25e-06	4.26e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—breast cancer	6.24e-06	4.25e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTHFR—breast cancer	6.2e-06	4.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—breast cancer	6.18e-06	4.21e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ABCB1—breast cancer	6.05e-06	4.12e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CAV1—breast cancer	6.03e-06	4.11e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGFR1—breast cancer	6e-06	4.09e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK3—breast cancer	5.97e-06	4.07e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TYMS—breast cancer	5.94e-06	4.05e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CA—breast cancer	5.92e-06	4.03e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HIF1A—breast cancer	5.91e-06	4.03e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CA—breast cancer	5.9e-06	4.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PLA2G4A—breast cancer	5.88e-06	4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOR1—breast cancer	5.88e-06	4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTM1—breast cancer	5.88e-06	4e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MYC—breast cancer	5.81e-06	3.95e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TGFB1—breast cancer	5.8e-06	3.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.76e-06	3.92e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—breast cancer	5.75e-06	3.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CAV1—breast cancer	5.72e-06	3.89e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGFR—breast cancer	5.68e-06	3.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GPX1—breast cancer	5.63e-06	3.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1A1—breast cancer	5.57e-06	3.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ERCC2—breast cancer	5.52e-06	3.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CG—breast cancer	5.5e-06	3.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOS2—breast cancer	5.38e-06	3.66e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—breast cancer	5.37e-06	3.65e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOTCH1—breast cancer	5.33e-06	3.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KIT—breast cancer	5.21e-06	3.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APC—breast cancer	5.21e-06	3.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTHFR—breast cancer	5.19e-06	3.54e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGF—breast cancer	5.15e-06	3.51e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CA—breast cancer	4.93e-06	3.36e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BRAF—breast cancer	4.9e-06	3.33e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—breast cancer	4.84e-06	3.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CD—breast cancer	4.83e-06	3.29e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—breast cancer	4.82e-06	3.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CAV1—breast cancer	4.79e-06	3.26e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—breast cancer	4.77e-06	3.25e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALB—breast cancer	4.77e-06	3.25e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT2—breast cancer	4.77e-06	3.24e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CD—breast cancer	4.58e-06	3.12e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.58e-06	3.12e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—breast cancer	4.56e-06	3.11e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NOS3—breast cancer	4.56e-06	3.11e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SERPINE1—breast cancer	4.53e-06	3.08e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—breast cancer	4.37e-06	2.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CG—breast cancer	4.36e-06	2.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOS3—breast cancer	4.32e-06	2.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CB—breast cancer	4.21e-06	2.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—breast cancer	4.17e-06	2.84e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MDM2—breast cancer	4.1e-06	2.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RAF1—breast cancer	4.09e-06	2.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB2—breast cancer	4.05e-06	2.75e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—breast cancer	4.03e-06	2.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTOR—breast cancer	3.99e-06	2.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CB—breast cancer	3.99e-06	2.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CD4—breast cancer	3.98e-06	2.71e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CD—breast cancer	3.84e-06	2.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALB—breast cancer	3.79e-06	2.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1B—breast cancer	3.75e-06	2.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—breast cancer	3.64e-06	2.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NOS3—breast cancer	3.62e-06	2.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CTNNB1—breast cancer	3.54e-06	2.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1A—breast cancer	3.46e-06	2.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—breast cancer	3.45e-06	2.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CB—breast cancer	3.34e-06	2.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SRC—breast cancer	3.2e-06	2.18e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT3—breast cancer	3.08e-06	2.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAPK3—breast cancer	2.95e-06	2.01e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—breast cancer	2.89e-06	1.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MYC—breast cancer	2.87e-06	1.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFB1—breast cancer	2.86e-06	1.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGFR—breast cancer	2.8e-06	1.91e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—breast cancer	2.65e-06	1.8e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CA—breast cancer	2.57e-06	1.75e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CA—breast cancer	2.43e-06	1.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—breast cancer	2.25e-06	1.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—breast cancer	2.15e-06	1.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—breast cancer	2.1e-06	1.43e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CA—breast cancer	2.04e-06	1.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—breast cancer	1.99e-06	1.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—breast cancer	1.66e-06	1.13e-05	CbGpPWpGaD
